We are proud to announce a new non-profit called Tinnitus Quest, which is fully dedicated to silencing tinnitus through funding ‘high risk, high gain’ studies. Join us in our ‘quiet revolution’.
Good Tinnitus Science, Bad Tinnitus Science
We need more tinnitus research. But mostly, we need high quality research. In reality, studies are often lacking rigor and proper design, and results can be misleading for patients. How can we improve this?
Revisiting a Friend of Tinnitus Talk — Dr. Josef Rauschecker
Revisiting with the first ever guest of the podcast, Hazel speaks with Dr. Rauschecker about how we can quickly get new tinnitus medications to market, tinnitus and sleep, what he thinks of psychological treatments for tinnitus, and more.
Can Sound Silence Tinnitus?
Maybe you heard of sound therapy devices like Neuromonics, Desyncra, and SoundCure? Or more recently, Lenire? Hazel talks to Steve Harrison, a musician and audiophile who has suffered from severe tinnitus for decades. Steve knows all about the use of sound for tinnitus relief.
The Man Who Donated a Million Dollars to Tinnitus Research
Meet the man who donated a million dollars to tinnitus research. Brian Fargo is a successful video game developer who tried out every possible treatment for his tinnitus before deciding he needed to be part of the solution.
It’s the Data, Stupid! — Christopher Cederroth and David Stockdale
How many people have chronic, severe tinnitus? What types of tinnitus exist? And why do clinical trials for tinnitus keep failing? The answers to all those questions lie in biobank data.
Tinnitus Realities — Steve and Sean
Hazel, Steve, and Sean share their darkest moments with tinnitus, and discuss tips and tricks for coping. How do you find what works for you? And how do you explain your experience to others?
Tinnitus, Ingrained in the Brain? — Prof. Dirk De Ridder
Prof. Dirk De Ridder is one of the most cited tinnitus researchers, a very eloquent speaker, and a passionate advocate for more and better tinnitus research. He seeks solutions to tinnitus in previously unexplored areas.
The Sound of Science — Otonomy
According to David Weber, CEO of Otonomy, there are signs of heightened interest among investors in hearing science. This is good news for all of us. We take a deep dive with Otonomy’s executives into their drug pipeline, covering hearing loss and tinnitus.
Objectifying Tinnitus — The Bionics Institute
Tinnitus has always seemed ungraspable; you hear something that others do not. How can we measure this objectively? The Bionics Institute believes they can. If they are right, this would be a breakthrough in supporting the development of better treatments for tinnitus.